GHUCCTS

News

Share This
  • Jan 05, 2021

Deadline Extended: 2021 KL2 Scholars Program Application

The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) is now accepting applications for our 2021 KL2 Scholars Program. The pre-application is due January 31, 2021 with the final application due February 28, 2021. Funding is expected to begin in June 2021 pending the evolution of the COVID-19 pandemic.

During our first ten years, we have been privileged to award KL2 support to 18 junior faculty colleagues from Georgetown and Howard Universities and from MedStar Health, who have leveraged this opportunity in order to publish >500 peer-reviewed manuscripts, receive over 50 extramural grants and conduct 30 sponsored clinical trials.

This K-series career development award is nearly identical to our previous KL2 awards and analogous to individual K23, K08, or K01 awards, with a focus on developing early-career (MD or equivalent; doctorally-trained nurses, pharmacists or dentists; and clinically or translationally-oriented PhD) faculty investigators through an inter- or multi-disciplinary mentored research experience so that they can become independent, extramurally-funded investigators. Given the goals of the GHUCCTS, awards will favor those: 1) who propose novel trans-, inter-, or multi-disciplinary and collaborative/team research projects, 2) from the entire T1-T4 translational continuum, 3) which span departments, disciplines, and institutions, and 4) address significant health disparities.

For more details, including application instructions, visit our KL2 Scholars page or download the RFA announcement

Related News

Request for Applications: 2022 KL2 Scholars Program

Mar 10, 2022

The GHUCCTS KL2 Scholars Program is now accepting applications for our 2022 funding cycle. Applicants must have a full-time faculty or equivalent appointment at a GHUCCTS institution (Georgetown University, Howard University, or MedStar Health) at the time of award activation.

Request for Applications: 2022-2023 TL1 Translational Biomedical Science Program

Mar 07, 2022

The GHUCCTS TL1 Translational Biomedical Science (TBS) Program is now accepting applications for our 2022-2023 funding cycle. Applicants should be predoctoral students who have completed their qualifying exams in PhD programs at Howard or Georgetown Universities or Postdoctoral fellows who have a primary appointment at Georgetown or Howard Universities, a MedStar Institution, or the Washington DC VAMC.

Close